Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.
Egbring
R
R
Department of Hematology/Oncology, University of Marburg, F.R.G.
Seitz
R
R
Blanke
H
H
Menges
T
T
Südhoff
R
R
Stober
T
T
Kolb
G
G
Lerch
L
L
D000990:Antithrombin III / Q000378:metabolism / Q000627:therapeutic use*; D001803:Blood Transfusion; D005344:Fibrinopeptide A / Q000378:metabolism; D005345:Fibrinopeptide B / Q000378:metabolism; D006801:Humans; D007118:Immunoassay; D007700:Kinetics; D019272:Leukocyte Elastase; D010196:Pancreatic Elastase / Q000032:analysis / Q000097:blood; D010949:Plasma; D010976:Platelet Count; D011480:Protease Inhibitors / Q000097:blood*; D018805:Sepsis / Q000097:blood / Q000628:therapy*; D013917:Thrombin / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000032:analysis / Q000378:metabolism
D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; C037741:alpha 1-antitrypsin-leukocyte elastase complex; D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D000990:Antithrombin III; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase; D013917:Thrombin